Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate: targets the outer surface protein A (OspA) of Borrelia burgdorferi... and covers the six OspA serotypes that are prevalent in North America & Europe

Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate: targets the outer surface protein A (OspA) of Borrelia burgdorferi... and covers the six OspA serotypes that are prevalent in North America & Europe: https://ift.tt/39ZROKu Read more... https://ift.tt/3A1m0zD